Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study.
- 1Xihu District Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.
Abstract
Background
Lung cancer is the leading cause of cancer-related death globally, with a significant burden in China, which accounts for more than one-third of the world's new cases and 40% of related mortalities. Despite evidence that low-dose computed tomography screening can reduce mortality, its limited uptake in China means that most patients are diagnosed at an advanced stage, contributing to a low 5-year survival rate compared to high-income countries. Although overall incidence trends have been well documented, there is a scarcity of population-based data on the temporal trends of different histological subtypes of lung cancer in China.Objective
This study aimed to analyze population-based cancer registry data to assess lung cancer incidence trends by histological subtype and sex from 2001 to 2020 and to forecast future incidence rates through 2030 in Xihu District, Hangzhou, Zhejiang Province, eastern China.Methods
The study used population-based surveillance data from the Xihu Cancer Registry from 2001 to 2020. Statistical analyses were conducted to assess the burden of each tumor subtype, including the average annual percentage change (AAPC) to evaluate temporal trends and the Bayesian age-period-cohort (BAPC) model to forecast incidence rates through 2030.Results
Lung cancer incidence rates were generally low among individuals aged <45 years but escalated markedly with age, reaching a peak of 567.6 per 100,000 person-years in among those aged 80 to 84 years. Notably, a significant rise in incidence was observed among those aged 30 to 44 years in recent years. Sex-based differences in histological distribution were pronounced. Adenocarcinoma accounted for 66.65% (2322/3484) of female cases compared to 37.1% (1795/4838) of male cases, while squamous-cell carcinoma was substantially less common in female cases (86/3484, 2.47% compared to 829/4838, 17.13% in male cases). Among male cases, the age-standardized incidence rates (ASIRs) of adenocarcinoma increased from 1.39 to 42.18 per 100,000 between 2001 and 2020; among female cases, the corresponding increase was even more pronounced, rising from 2.81 to 67.37 per 100,000. Joinpoint regression analysis demonstrated a consistent long-term increase in adenocarcinoma (AAPC=35.1, 95% CI 14.2-50.2), with peak acceleration observed from 2005 to 2012 (annual percentage change [APC]=76.7, 95% CI 45.2-124.2), and a steady increase in large-cell and other specified carcinomas (AAPC=32.7, 95% CI 12.5-45.7), while unspecified carcinoma showed a long-term decline (AAPC=-3.1, 95% CI -14.2 to -1.1). BAPC projections indicated that adenocarcinoma ASIR will continue to surge between 2020 and 2030, emerging as the dominant histological subtype, while unspecified carcinoma, squamous-cell carcinoma, and small-cell lung cancer are anticipated to decline modestly.Conclusions
The increase in lung cancer incidence, particularly among female participants, underscores the need for effective prevention and control strategies, including targeted interventions to reduce smoking.
Related
- Temporal trends in incidence, clinical characteristics and outcomes of pyogenic vertebral osteomyelitis in Southern Denmark from 2009 to 2022: a retrospective population-based cohort study.
- Temporal trends and disparities in oral cavity and oropharyngeal squamous cell carcinoma incidence in Saudi Arabia, 2000–2019: a nationwide population-based study
- Mapping the COVID-19 epidemic in Lombardy, Italy, years 2020–2022: a population-based study of temporal trends, geographic distribution, and risk factors for incidence, hospitalization, and mortality
- Temporal Observations of Multifidus Muscle Injury and Degeneration Following Posterior Thoracolumbar Spine Surgery: A Clinical Histological Study over a Three-Year Time Period
- The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections
BibTeX
@article{su2026temporal,
title = {{Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study.}},
author = {Xing Su and Jing Li and Xiaowei Hu},
journal = {JMIR public health and surveillance},
year = {2026},
month = oct,
doi = {10.2196/98324},
url = {https://europepmc.org/article/MED/42837657},
note = {CC BY},
}
RIS
TY - JOUR
TI - Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study.
AU - Xing Su
AU - Jing Li
AU - Xiaowei Hu
PY - 2026
DA - 2026/10/06
JO - JMIR public health and surveillance
DO - 10.2196/98324
UR - https://europepmc.org/article/MED/42837657
AB - Background Lung cancer is the leading cause of cancer-related death globally, with a significant burden in China, which accounts for more than one-third of the world's new cases and 40% of related mortalities. Despite evidence that low-dose computed tomography screening can reduce mortality, its limited uptake in China means that most patients are diagnosed at an advanced stage, contributing to a low 5-year survival rate compared to high-income countries. Although overall incidence trends have been well documented, there is a scarcity of population-based data on the temporal trends of different histological subtypes of lung cancer in China.Objective This study aimed to analyze population-based cancer registry data to assess lung cancer incidence trends by histological subtype and sex from 2001 to 2020 and to forecast future incidence rates through 2030 in Xihu District, Hangzhou, Zhejiang Province, eastern China.Methods The study used population-based surveillance data from the Xihu Cancer Registry from 2001 to 2020. Statistical analyses were conducted to assess the burden of each tumor subtype, including the average annual percentage change (AAPC) to evaluate temporal trends and the Bayesian age-period-cohort (BAPC) model to forecast incidence rates through 2030.Results Lung cancer incidence rates were generally low among individuals aged <45 years but escalated markedly with age, reaching a peak of 567.6 per 100,000 person-years in among those aged 80 to 84 years. Notably, a significant rise in incidence was observed among those aged 30 to 44 years in recent years. Sex-based differences in histological distribution were pronounced. Adenocarcinoma accounted for 66.65% (2322/3484) of female cases compared to 37.1% (1795/4838) of male cases, while squamous-cell carcinoma was substantially less common in female cases (86/3484, 2.47% compared to 829/4838, 17.13% in male cases). Among male cases, the age-standardized incidence rates (ASIRs) of adenocarcinoma increased from 1.39 to 42.18 per 100,000 between 2001 and 2020; among female cases, the corresponding increase was even more pronounced, rising from 2.81 to 67.37 per 100,000. Joinpoint regression analysis demonstrated a consistent long-term increase in adenocarcinoma (AAPC=35.1, 95% CI 14.2-50.2), with peak acceleration observed from 2005 to 2012 (annual percentage change [APC]=76.7, 95% CI 45.2-124.2), and a steady increase in large-cell and other specified carcinomas (AAPC=32.7, 95% CI 12.5-45.7), while unspecified carcinoma showed a long-term decline (AAPC=-3.1, 95% CI -14.2 to -1.1). BAPC projections indicated that adenocarcinoma ASIR will continue to surge between 2020 and 2030, emerging as the dominant histological subtype, while unspecified carcinoma, squamous-cell carcinoma, and small-cell lung cancer are anticipated to decline modestly.Conclusions The increase in lung cancer incidence, particularly among female participants, underscores the need for effective prevention and control strategies, including targeted interventions to reduce smoking.
SN - 2369-2960
ER -